Importing generic medicines from India can deliver substantial savings, but the regulatory landscape is complex and varies significantly by destination country. This guide walks buyers through the key regulatory requirements, documentation, and compliance steps needed to import Indian generic medicines legally and safely in 2026.
📁 Know Your Destination Country’s Rules First
There is no universal “import Indian medicines” checklist. Every country has its own drug import laws, and what is perfectly legal in India may be restricted, unapproved, or outright prohibited in your destination country. Before placing any order, confirm:
- Is the specific drug approved for sale or personal import in your country? Check with your national drug regulator (e.g., FDA in the US, MHRA in the UK, TGA in Australia, Health Canada).
- What is the personal import allowance? Some countries permit individuals to import a limited quantity of unapproved medicines for personal use with a doctor’s letter. Others ban personal import entirely.
- Does the drug require prior authorization? Several countries require an import permit or no-objection certificate before any medicine shipment crosses the border.
- Are there controlled substance restrictions? Certain active ingredients (e.g., codeine, tramadol, psychotropic medications) are subject to international narcotics control treaties and additional licensing.
📦 Essential Documentation for Every Import
Regardless of destination, every legitimate import of Indian generic medicines should be accompanied by the following documentation. Reputable Indian manufacturers and exporters will provide these on request — if a supplier refuses or cannot produce them, treat it as a red flag.
- Certificate of Analysis (CoA): A batch-specific document from the manufacturer’s quality control laboratory confirming the drug meets pharmacopoeial standards for identity, purity, potency, and dissolution. The CoA must reference the batch number on the packaging.
- Manufacturing License Number: Indian drug manufacturers must hold a valid license issued by the state drug control authority under the Drugs and Cosmetics Act, 1940. The license number (often prefixed with the state code, e.g., “MH” for Maharashtra, “TN” for Tamil Nadu) should appear on the packaging or be provided as a separate certificate.
- Export Documentation: A commercial invoice with full product details (drug name, strength, quantity, batch number, manufacturing and expiry dates, manufacturer name and address). A packing list and bill of lading/airway bill are standard shipping documents.
- GMP or WHO-GMP Certificate: Evidence that the manufacturing facility is certified under Good Manufacturing Practices. WHO-GMP certification is the most widely recognized international standard and is issued by authorized inspectorates.
- Letter of Prescriptions / Doctor’s Prescription: For personal imports, most countries require a valid prescription from a licensed physician in the destination country. The prescription should specify the drug name, strength, quantity, and the medical condition being treated.
- Import Permit or No-Objection Certificate (if required): Some national regulators require advance approval before a medicine shipment is allowed entry. This is common for unapproved new drugs, controlled substances, and large commercial quantities.
📦 India’s Export-Side Requirements
India’s drug regulatory framework governs the export of pharmaceuticals through the Drugs and Cosmetics Act and Rules. Key points every importer should understand about the Indian side:
- CDSCO Oversight: The Central Drugs Standard Control Organization (CDSCO) sets the national standards for drug manufacturing, quality, and export. All legitimate Indian drug manufacturers must comply with CDSCO regulations regardless of where they export.
- Schedule H Labeling: Prescription drugs in India must carry the Schedule H symbol on packaging, indicating they require a doctor’s prescription. Importing Schedule H drugs without a valid prescription in your country is illegal.
- QR Code Traceability (2026): India has expanded mandatory QR code requirements on drug packaging for traceability. As reported by RAPS on June 29, 2026, the phased rollout now covers additional categories including vaccines and cancer drugs (per The Tribune, June 25, 2026). QR codes on packaging can be scanned to verify the drug’s authenticity and manufacturing details.
- Export Inspection Council (EIC): For certain export markets, the EIC of India provides pre-shipment inspection and certification. Check whether your destination country requires EIC certification for pharmaceutical imports from India.
🏠 Country-Specific Considerations (2026 Snapshot)
The following is a general overview of how major markets approach imports of Indian generic medicines as of 2026. This is not legal advice — consult your national drug regulator or a customs broker for case-specific guidance.
United States
The US FDA allows personal importation of unapproved drugs under limited circumstances through its “personal use” policy, but this is discretionary and not a right. The FDA generally permits individuals to import a 90-day supply of medicine for personal use if: the drug is for a serious condition, there is no effective US treatment available, and the drug is not for a condition that poses potentially serious health risks. Commercial importation of generic drugs from India for resale is prohibited without FDA approval and an established US drug listing. Note: The Trump administration’s phased generic drug tariff plan (0% now, rising to 100% by ~2028 and 200% by ~2029) as reported by Clinical Leader on August 7, 2026, significantly reshapes the economics of importing Indian generics for commercial distribution into the US market.
United Kingdom
The UK MHRA permits individuals to import medicines for personal use under the “personal import” provisions, typically a 3-month supply. The medicine must be for the importer’s own personal use, and a valid UK prescription or doctor’s letter is generally expected. Importing medicines for resale without a wholesale dealer’s license is illegal. Post-Brexit, UK import rules operate independently from EU regulations.
European Union
EU member states have varying national rules for personal medicine imports. The European Medicines Agency (EMA) does not directly regulate personal imports — this is handled by national competent authorities. Many EU countries allow travelers to carry personal medication quantities (typically up to 3 months’ supply) with a prescription or medical certificate. Commercial imports require the drug to be authorized in the destination EU member state or to go through the mutual recognition or centralized authorization procedure.
Australia
The Therapeutic Goods Administration (TGA) allows personal importation of medicines under the “personal importation scheme” for a maximum 3-month supply. The medicine must be for the importer’s personal use, and the importer must hold a valid prescription from an Australian-registered medical practitioner. The TGA maintains a list of medicines that cannot be imported under any circumstances (including certain controlled substances and unapproved ingredients). Commercial importation requires the medicine to be listed on the Australian Register of Therapeutic Goods (ARTG) or to go through a special access scheme.
📦 Practical Step-by-Step Import Workflow
- Step 1 — Confirm drug legality: Verify with your national drug regulator that the specific drug (active ingredient, strength, dosage form) is legal to import in the quantity you need.
- Step 2 — Obtain a prescription: If the drug is prescription-only in your country, get a current, valid prescription from your licensed physician. Some regulators also accept a doctor’s letter explaining the medical necessity.
- Step 3 — Source from a verified supplier: Use the IMSDA’s verified member directory to find legitimate Indian pharmaceutical manufacturers and distributors with verified credentials. Avoid unverified online marketplaces and social media sellers.
- Step 4 — Request full documentation: Before payment, ask the supplier for the CoA, manufacturing license, GMP certificate, and a draft commercial invoice. Verify that the batch number on the CoA matches the packaging.
- Step 5 — Check import permits: If your country requires an import permit or no-objection certificate, apply well in advance — processing can take weeks.
- Step 6 — Use a tracked shipping method: Choose a courier or freight forwarder experienced in pharmaceutical shipments. Ensure the shipment is properly declared on the customs form, and that temperature-sensitive products (if applicable) are shipped with appropriate cold-chain measures.
- Step 7 — Retain all documentation: Keep copies of the prescription, CoA, invoice, packing list, and shipping documents. Customs authorities may request these at the border.
🚨 Red Flags in Import Transactions
Be cautious if any of the following apply to your potential import:
- The supplier cannot or will not provide a batch-specific Certificate of Analysis.
- The drug is being sold without any prescription requirement despite being a controlled or prescription-only medicine.
- The price is dramatically lower than the known market rate for the same drug — this can indicate substandard, counterfeit, or expired stock.
- The supplier has no verifiable business address, license number, or online presence in India.
- The drug packaging lacks the Schedule H symbol (for prescription drugs), batch number, expiry date, or manufacturer details.
- The shipping method is untracked, un-insured, or uses a personal parcel service that cannot handle temperature-controlled pharmaceuticals.
- The supplier requests payment via irreversible methods (wire transfer to a personal account, cryptocurrency) with no escrow or buyer protection.
📄 Key Takeaways
- There is no one-size-fits-all import process — your destination country’s drug regulator is the ultimate authority.
- Documentation is non-negotiable: CoA, manufacturing license, GMP certificate, prescription, and invoices are the minimum for any legitimate import.
- India has strengthened drug traceability with expanded QR code requirements on packaging in 2026 — use this to verify authenticity.
- The US generic drug tariff environment is shifting rapidly under the Trump administration’s phased plan; commercial importers need to factor tariff timelines into their cost calculations.
- Use verified suppliers: the IMSDA’s verified member directory provides a starting point for finding legitimate Indian pharmaceutical distributors.
Disclaimer: This guide is for informational purposes only and does not constitute legal or regulatory advice. Import laws vary by country and change over time. Always consult your national drug regulator and/or a qualified customs broker before importing any pharmaceutical products.
For more information, contact IMSDA at contact@indiamedicine.org.
Regardless of destination, every legitimate import of Indian generic medicines should be accompanied by the following documentation. Reputable Indian manufacturers and exporters will provide these on request — if a supplier refuses or cannot produce them, treat it as a red flag.
- Certificate of Analysis (CoA): A batch-specific document from the manufacturer’s quality control laboratory confirming the drug meets pharmacopoeial standards for identity, purity, potency, and dissolution. The CoA must reference the batch number on the packaging.
- Manufacturing License Number: Indian drug manufacturers must hold a valid license issued by the state drug control authority under the Drugs and Cosmetics Act, 1940. The license number (often prefixed with the state code, e.g., “MH” for Maharashtra, “TN” for Tamil Nadu) should appear on the packaging or be provided as a separate certificate.
- Export Documentation: A commercial invoice with full product details (drug name, strength, quantity, batch number, manufacturing and expiry dates, manufacturer name and address). A packing list and bill of lading/airway bill are standard shipping documents.
- GMP or WHO-GMP Certificate: Evidence that the manufacturing facility is certified under Good Manufacturing Practices. WHO-GMP certification is the most widely recognized international standard and is issued by authorized inspectorates.
- Letter of Prescriptions / Doctor’s Prescription: For personal imports, most countries require a valid prescription from a licensed physician in the destination country. The prescription should specify the drug name, strength, quantity, and the medical condition being treated.
- Import Permit or No-Objection Certificate (if required): Some national regulators require advance approval before a medicine shipment is allowed entry. This is common for unapproved new drugs, controlled substances, and large commercial quantities.
📦 India’s Export-Side Requirements
India’s drug regulatory framework governs the export of pharmaceuticals through the Drugs and Cosmetics Act and Rules. Key points every importer should understand about the Indian side:
- CDSCO Oversight: The Central Drugs Standard Control Organization (CDSCO) sets the national standards for drug manufacturing, quality, and export. All legitimate Indian drug manufacturers must comply with CDSCO regulations regardless of where they export.
- Schedule H Labeling: Prescription drugs in India must carry the Schedule H symbol on packaging, indicating they require a doctor’s prescription. Importing Schedule H drugs without a valid prescription in your country is illegal.
- QR Code Traceability (2026): India has expanded mandatory QR code requirements on drug packaging for traceability. As reported by RAPS on June 29, 2026, the phased rollout now covers additional categories including vaccines and cancer drugs (per The Tribune, June 25, 2026). QR codes on packaging can be scanned to verify the drug’s authenticity and manufacturing details.
- Export Inspection Council (EIC): For certain export markets, the EIC of India provides pre-shipment inspection and certification. Check whether your destination country requires EIC certification for pharmaceutical imports from India.
🏠 Country-Specific Considerations (2026 Snapshot)
The following is a general overview of how major markets approach imports of Indian generic medicines as of 2026. This is not legal advice — consult your national drug regulator or a customs broker for case-specific guidance.
United States
The US FDA allows personal importation of unapproved drugs under limited circumstances through its “personal use” policy, but this is discretionary and not a right. The FDA generally permits individuals to import a 90-day supply of medicine for personal use if: the drug is for a serious condition, there is no effective US treatment available, and the drug is not for a condition that poses potentially serious health risks. Commercial importation of generic drugs from India for resale is prohibited without FDA approval and an established US drug listing. Note: The Trump administration’s phased generic drug tariff plan (0% now, rising to 100% by ~2028 and 200% by ~2029) as reported by Clinical Leader on August 7, 2026, significantly reshapes the economics of importing Indian generics for commercial distribution into the US market.
United Kingdom
The UK MHRA permits individuals to import medicines for personal use under the “personal import” provisions, typically a 3-month supply. The medicine must be for the importer’s own personal use, and a valid UK prescription or doctor’s letter is generally expected. Importing medicines for resale without a wholesale dealer’s license is illegal. Post-Brexit, UK import rules operate independently from EU regulations.
European Union
EU member states have varying national rules for personal medicine imports. The European Medicines Agency (EMA) does not directly regulate personal imports — this is handled by national competent authorities. Many EU countries allow travelers to carry personal medication quantities (typically up to 3 months’ supply) with a prescription or medical certificate. Commercial imports require the drug to be authorized in the destination EU member state or to go through the mutual recognition or centralized authorization procedure.
Australia
The Therapeutic Goods Administration (TGA) allows personal importation of medicines under the “personal importation scheme” for a maximum 3-month supply. The medicine must be for the importer’s personal use, and the importer must hold a valid prescription from an Australian-registered medical practitioner. The TGA maintains a list of medicines that cannot be imported under any circumstances (including certain controlled substances and unapproved ingredients). Commercial importation requires the medicine to be listed on the Australian Register of Therapeutic Goods (ARTG) or to go through a special access scheme.
📦 Practical Step-by-Step Import Workflow
- Step 1 — Confirm drug legality: Verify with your national drug regulator that the specific drug (active ingredient, strength, dosage form) is legal to import in the quantity you need.
- Step 2 — Obtain a prescription: If the drug is prescription-only in your country, get a current, valid prescription from your licensed physician. Some regulators also accept a doctor’s letter explaining the medical necessity.
- Step 3 — Source from a verified supplier: Use the IMSDA’s verified member directory to find legitimate Indian pharmaceutical manufacturers and distributors with verified credentials. Avoid unverified online marketplaces and social media sellers.
- Step 4 — Request full documentation: Before payment, ask the supplier for the CoA, manufacturing license, GMP certificate, and a draft commercial invoice. Verify that the batch number on the CoA matches the packaging.
- Step 5 — Check import permits: If your country requires an import permit or no-objection certificate, apply well in advance — processing can take weeks.
- Step 6 — Use a tracked shipping method: Choose a courier or freight forwarder experienced in pharmaceutical shipments. Ensure the shipment is properly declared on the customs form, and that temperature-sensitive products (if applicable) are shipped with appropriate cold-chain measures.
- Step 7 — Retain all documentation: Keep copies of the prescription, CoA, invoice, packing list, and shipping documents. Customs authorities may request these at the border.
🚨 Red Flags in Import Transactions
Be cautious if any of the following apply to your potential import:
- The supplier cannot or will not provide a batch-specific Certificate of Analysis.
- The drug is being sold without any prescription requirement despite being a controlled or prescription-only medicine.
- The price is dramatically lower than the known market rate for the same drug — this can indicate substandard, counterfeit, or expired stock.
- The supplier has no verifiable business address, license number, or online presence in India.
- The drug packaging lacks the Schedule H symbol (for prescription drugs), batch number, expiry date, or manufacturer details.
- The shipping method is untracked, un-insured, or uses a personal parcel service that cannot handle temperature-controlled pharmaceuticals.
- The supplier requests payment via irreversible methods (wire transfer to a personal account, cryptocurrency) with no escrow or buyer protection.
📄 Key Takeaways
- There is no one-size-fits-all import process — your destination country’s drug regulator is the ultimate authority.
- Documentation is non-negotiable: CoA, manufacturing license, GMP certificate, prescription, and invoices are the minimum for any legitimate import.
- India has strengthened drug traceability with expanded QR code requirements on packaging in 2026 — use this to verify authenticity.
- The US generic drug tariff environment is shifting rapidly under the Trump administration’s phased plan; commercial importers need to factor tariff timelines into their cost calculations.
- Use verified suppliers: the IMSDA’s verified member directory provides a starting point for finding legitimate Indian pharmaceutical distributors.
Disclaimer: This guide is for informational purposes only and does not constitute legal or regulatory advice. Import laws vary by country and change over time. Always consult your national drug regulator and/or a qualified customs broker before importing any pharmaceutical products.
For more information, contact IMSDA at contact@indiamedicine.org.
The following is a general overview of how major markets approach imports of Indian generic medicines as of 2026. This is not legal advice — consult your national drug regulator or a customs broker for case-specific guidance.
United States
The US FDA allows personal importation of unapproved drugs under limited circumstances through its “personal use” policy, but this is discretionary and not a right. The FDA generally permits individuals to import a 90-day supply of medicine for personal use if: the drug is for a serious condition, there is no effective US treatment available, and the drug is not for a condition that poses potentially serious health risks. Commercial importation of generic drugs from India for resale is prohibited without FDA approval and an established US drug listing. Note: The Trump administration’s phased generic drug tariff plan (0% now, rising to 100% by ~2028 and 200% by ~2029) as reported by Clinical Leader on August 7, 2026, significantly reshapes the economics of importing Indian generics for commercial distribution into the US market.
United Kingdom
The UK MHRA permits individuals to import medicines for personal use under the “personal import” provisions, typically a 3-month supply. The medicine must be for the importer’s own personal use, and a valid UK prescription or doctor’s letter is generally expected. Importing medicines for resale without a wholesale dealer’s license is illegal. Post-Brexit, UK import rules operate independently from EU regulations.
European Union
EU member states have varying national rules for personal medicine imports. The European Medicines Agency (EMA) does not directly regulate personal imports — this is handled by national competent authorities. Many EU countries allow travelers to carry personal medication quantities (typically up to 3 months’ supply) with a prescription or medical certificate. Commercial imports require the drug to be authorized in the destination EU member state or to go through the mutual recognition or centralized authorization procedure.
Australia
The Therapeutic Goods Administration (TGA) allows personal importation of medicines under the “personal importation scheme” for a maximum 3-month supply. The medicine must be for the importer’s personal use, and the importer must hold a valid prescription from an Australian-registered medical practitioner. The TGA maintains a list of medicines that cannot be imported under any circumstances (including certain controlled substances and unapproved ingredients). Commercial importation requires the medicine to be listed on the Australian Register of Therapeutic Goods (ARTG) or to go through a special access scheme.
📦 Practical Step-by-Step Import Workflow
- Step 1 — Confirm drug legality: Verify with your national drug regulator that the specific drug (active ingredient, strength, dosage form) is legal to import in the quantity you need.
- Step 2 — Obtain a prescription: If the drug is prescription-only in your country, get a current, valid prescription from your licensed physician. Some regulators also accept a doctor’s letter explaining the medical necessity.
- Step 3 — Source from a verified supplier: Use the IMSDA’s verified member directory to find legitimate Indian pharmaceutical manufacturers and distributors with verified credentials. Avoid unverified online marketplaces and social media sellers.
- Step 4 — Request full documentation: Before payment, ask the supplier for the CoA, manufacturing license, GMP certificate, and a draft commercial invoice. Verify that the batch number on the CoA matches the packaging.
- Step 5 — Check import permits: If your country requires an import permit or no-objection certificate, apply well in advance — processing can take weeks.
- Step 6 — Use a tracked shipping method: Choose a courier or freight forwarder experienced in pharmaceutical shipments. Ensure the shipment is properly declared on the customs form, and that temperature-sensitive products (if applicable) are shipped with appropriate cold-chain measures.
- Step 7 — Retain all documentation: Keep copies of the prescription, CoA, invoice, packing list, and shipping documents. Customs authorities may request these at the border.
🚨 Red Flags in Import Transactions
Be cautious if any of the following apply to your potential import:
- The supplier cannot or will not provide a batch-specific Certificate of Analysis.
- The drug is being sold without any prescription requirement despite being a controlled or prescription-only medicine.
- The price is dramatically lower than the known market rate for the same drug — this can indicate substandard, counterfeit, or expired stock.
- The supplier has no verifiable business address, license number, or online presence in India.
- The drug packaging lacks the Schedule H symbol (for prescription drugs), batch number, expiry date, or manufacturer details.
- The shipping method is untracked, un-insured, or uses a personal parcel service that cannot handle temperature-controlled pharmaceuticals.
- The supplier requests payment via irreversible methods (wire transfer to a personal account, cryptocurrency) with no escrow or buyer protection.
📄 Key Takeaways
- There is no one-size-fits-all import process — your destination country’s drug regulator is the ultimate authority.
- Documentation is non-negotiable: CoA, manufacturing license, GMP certificate, prescription, and invoices are the minimum for any legitimate import.
- India has strengthened drug traceability with expanded QR code requirements on packaging in 2026 — use this to verify authenticity.
- The US generic drug tariff environment is shifting rapidly under the Trump administration’s phased plan; commercial importers need to factor tariff timelines into their cost calculations.
- Use verified suppliers: the IMSDA’s verified member directory provides a starting point for finding legitimate Indian pharmaceutical distributors.
Disclaimer: This guide is for informational purposes only and does not constitute legal or regulatory advice. Import laws vary by country and change over time. Always consult your national drug regulator and/or a qualified customs broker before importing any pharmaceutical products.
For more information, contact IMSDA at contact@indiamedicine.org.
Be cautious if any of the following apply to your potential import:
- The supplier cannot or will not provide a batch-specific Certificate of Analysis.
- The drug is being sold without any prescription requirement despite being a controlled or prescription-only medicine.
- The price is dramatically lower than the known market rate for the same drug — this can indicate substandard, counterfeit, or expired stock.
- The supplier has no verifiable business address, license number, or online presence in India.
- The drug packaging lacks the Schedule H symbol (for prescription drugs), batch number, expiry date, or manufacturer details.
- The shipping method is untracked, un-insured, or uses a personal parcel service that cannot handle temperature-controlled pharmaceuticals.
- The supplier requests payment via irreversible methods (wire transfer to a personal account, cryptocurrency) with no escrow or buyer protection.